Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Enzymotec Ltd. and Lead Plaintiff Deadline of November 4, 2014
NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court for the District of New Jersey on behalf of those who purchased shares of Enzymotec Ltd. ("Enzymotec" or the "Company") (NasdaqGS: ENZY), during the period traceable to the Company's Initial Public Offering (IPO) on or about September 27, 2013 or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period").
The complaint charges Enzymotec and certain of its executives with violations of federal securities laws. Specifically, the complaint alleges that: (a) Enzymotec's Chinese business was subject to material and readily identifiable compliance regulations from the Chinese government; (b) Enzymotec's baby formula business in China was jeopardized and subject to increased volatility and decreased revenues; and (c) Enzymotec's joint venture with AarhusKarlshamn AB, which marketed the popular InFat product, was crumbling and subjected the Company to liability and decreased revenues.
Plaintiff seeks to recover damages on behalf of all shareholders who purchased shares of Enzymotec during the Class Period described above.
No Class has yet been certified in the above action. If you wish to review a copy of the Complaint, to discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. November 4, 2014 is the deadline for investors to seek a lead plaintiff appointment. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
[email protected]
SOURCE Bronstein, Gewirtz & Grossman, LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article